Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
          • CER Template sections
            • 00 Front matter, introduction, writing tips
            • 1. Administrative particulars
            • 2. Executive summary
            • 3. Scope of the clinical evaluation
            • 4. Clinical evaluation plan — Summary
            • 5. Common specifications and harmonised standards
            • 6. Clinical background, current knowledge, state of the art
            • 7. Equivalence
            • 8. Clinical evidence review
            • 9. Clinical evidence analysis — GSPRs
            • 10. Clinical evidence analysis — Benefit-risk profile
            • 15. Vendor services annex (non-normative)
            • 11–14. Conclusions, Author CVs, References, Excluded sources
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)
  • CER Template sections
  • 11–14. Conclusions, Author CVs, References, Excluded sources

11–14. Conclusions, Author CVs, References, Excluded sources

Source: CER Template.pdf page 25 (document: Mantra Systems Free CER Template, Edition 2)

11. Conclusions​

In this section, provide closing remarks that draw the CER to a close.

Refer to the hypothesis outlined at the start of the CER and state whether the consideration of clinical evidence in the evaluation has proven the hypothesis to be true.

Describe if there is consistency between all documents and the current knowledge/state of the art. Are there any unacceptable residual risks?

Overall, is ongoing approval of the subject device supported?

12. Author CVs​

Include CVs of the authors of the CER.

13. References​

Include a bibliography of all sources used in the CER.

14. Excluded sources​

Include a record of each source excluded against each search term, along with a justification for exclusion of each.

Previous
15. Vendor services annex (non-normative)
Next
Overall conclusions
  • 11. Conclusions
  • 12. Author CVs
  • 13. References
  • 14. Excluded sources
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)